Rheumatology Advance Access published online on January 29, 2008
Rheumatology, doi:10.1093/rheumatology/kem367
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author 2008. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
Letter to the Editor |
RF latex and anti-CCP antibodies: a combined strategy for diagnosing RA in primary care?
1Department of Rheumatology and 2Department of Immunology, Wexham Park Hospital, Slough, Berks SL2 4HL, UK.
Correspondence to:
A. Steuer, Department of Rheumatology, Wexham Park Hospital, Slough, Berks SL2 4HL, UK. E-mail: alan.steuer@hwph-tr.nhs.uk
| The first 10% of the full text of this article appears below. |
SIR, Deborah Symmons makes a strong case in your recent editorial that RF testing should not be abandoned but used in conjunction with anti-cyclic citrullinated peptide (CCP) antibodies in the diagnosis of early RA in secondary care [1]. Whilst combining RF with anti-CCP antibodies may add some additional diagnostic and prognostic information, there is a consensus view that measuring anti-CCP antibodies